Increased uptake of quinine into the brain by inhibition of P-glycoprotein

European Journal of Pharmaceutical Sciences

Volumn 32, Issue 2, 2007, Pages 123-127

  Pussard, Eric ^a   Merzouk, Mourad ^a   Barennes, Hubert ^b  

^a BICÊTRE HOSPITAL   (France)

^b Institut de la Francophonie pour la Medecine Tropicale   (Laos)

Author keywords

Brain uptake; Drug interactions; Mice; P glycoprotein; Quinine

Indexed keywords

3 HYDROXYQUININE; ARTEMETHER; ARTESUNATE; CINCHONINE; CYCLOSPORIN A; DOXYCYCLINE; DRUG METABOLITE; ERYTHROMYCIN; GLYCOPROTEIN P; HALOFANTRINE; MEFLOQUINE; QUININE; UNCLASSIFIED DRUG; VERAPAMIL;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG TRANSFORMATION; DRUG UPTAKE; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOTRANSFORMATION; BRAIN; DATA INTERPRETATION, STATISTICAL; MICE; MICE, KNOCKOUT; P-GLYCOPROTEIN; P-GLYCOPROTEINS; QUININE;

EID: 34548134497     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2007.06.007     Document Type: Article

References (27)

1. Barennes H., Balima-Koussoube T., Nagot N., Charpentier J.C., and Pussard E. Safety and efficacy of rectal compared with intramuscular quinine for the early treatment of moderately severe malaria in children: randomised clinical trial. BMJ 332 (2006) 1055-1059
2. Barraud de Lagerie S., Comets E., Gautrand C., Fernandez C., Auchere D., Singlas E., Mentre F., and Gimenez F. Cerebral uptake of mefloquine enantiomers with and without the P-gp inhibitor elacridar (GF1210918) in mice. Br. J. Pharmacol. 141 (2004) 1214-1222
3. Ciach M., Zong K., Kain K.C., and Crandall I. Reversal of mefloquine and quinine resistance in Plasmodium falciparum with NP30. Antimicrob. Agents Chemother. 47 (2003) 2393-2396
4. Couet W., Laroche R., Floch J.J., Istin B., Fourtillan J.B., and Sauniere J.F. Pharmacokinetics of quinine and doxycycline in patients with acute falciparum malaria: a study in Africa. Ther. Drug Monit. 13 (1991) 496-501
5. Gala J.L., Noel H., Rodhain J., Ma D.F., and Ferrant A. P-glycoprotein positive, drug resistant invasive lymphoepithelial thymoma: treatment response to chemotherapy with cyclosporin and quinine. J. Clin. Pathol. 48 (1995) 679-681
6. Gavigan C.S., Shen M., Machado S.G., and Bell A. Influence of the Plasmodium falciparum P-glycoprotein homologue 1 (pfmdr1 gene product) on the antimalarial action of cyclosporin. J. Antimicrob. Chemother. 59 (2007) 197-203
7. Genne P., Duchamp O., Solary E., Pinard D., Belon J.P., Dimanche-Boitrel M.T., and Chauffert B. Comparative effects of quinine and cinchonine in reversing multidrug resistance on human leukemic cell line K562/ADM. Leukemia 8 (1994) 160-164
8. Hayeshi R., Masimirembwa C., Mukanganyama S., and Ungell A.L. The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux. Eur. J. Pharm. Sci. 29 (2006) 70-81
9. Jette L., Murphy G.F., Leclerc J.M., and Beliveau R. Interaction of drugs with P-glycoprotein in brain capillaries. Biochem. Pharmacol. 50 (1995) 1701-1709
10. Karbwang J., Bunnag D., Harinasuta T., Chittamas S., Berth J., and Druilhe P. Pharmacokinetics of quinine, quinidine and Cinchonine when given as combination. Southeast Asian J. Trop. Med. Public Health 23 (1992) 773-776
11. Keogh J.P., and Kunta J.R. Development, validation and utility of an in vitro technique for assessment of potential clinical drug-drug interactions involving P-glycoprotein. Eur. J. Pharm. Sci. 27 (2005) 543-554
12. Krishna S., and White N.J. Pharmacokinetics of quinine, chloroquine and amodiaquine: clinical implications. Clin. Pharmacokinet. 30 (1996) 263-299
13. Lehnert M., Dalton W.S., Roe D., Emerson S., and Salmon S.E. Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in a human myeloma cell line model. Blood 77 (1991) 348-354
14. Lirussi F., and Pussard E. Quinine distribution in pregnant mice with Plasmodium berghei malaria. Eur. J. Pharm. Sci. 28 (2006) 284-290
15. Miller R.S., Wongsrichanalai C., Buathong N., McDaniel P., Walsh D.S., Knirsch C., and Ohrt C. Effective treatment of uncomplicated Plasmodium falciparum malaria with azithromycin-quinine combinations: a randomized, dose-ranging study. Am. J. Trop. Med. Hyg. 74 (2006) 401-406
16. Mirghani R.A., Hellgren U., Bertilsson L., Gustafsson L.L., and Ericsson O. Metabolism and elimination of quinine in healthy volunteers. Eur. J. Clin. Pharmacol. 59 (2003) 423-427
17. Newton P.N., Chierakul W., Ruangveerayuth R., Silamut K., Teerapong P., Krudsood S., Looareesuwan S., and White N.J. A comparison of artesunate alone with combined artesunate and quinine in the parenteral treatment of acute falciparum malaria. Trans. R. Soc. Trop. Med. Hyg. 95 (2001) 519-523
18. Nobili S., Landini I., Giglioni B., and Mini E. Pharmacological strategies for overcoming multidrug resistance. Curr. Drug Targets 7 (2006) 861-879
19. Reed M.B., Saliba K.J., Caruana S.R., Kirk K., and Cowman A.F. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 403 (2000) 906-909
20. Schuetz E.G., Schinkel A.H., Relling M.V., and Schuetz J.D. P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 4001-4005
21. Silamut K., White N.J., Looareesuwan S., and Warrell D.A. Binding of quinine to plasma proteins in falciparum malaria. Am. J. Trop. Med. Hyg. 34 (1985) 681-686
22. Solary E., Witz F., Caillot D., Moreau P., Desablens B., Cahn J.Y., Sadoun A., Pignon B., Berthou C., Maloisel F., Guyotat D., Casassus P., Ifrah N., Lamy Y., Audhuy B., Colombat P., and Harousseau J.L. Combination of quinine as a potential reversing agent with mitoxantrone and cytarabine for the treatment of acute leukemias: a randomized multicentric study. Blood 88 (1996) 1198-1205
23. Sowunmi A., Salako L.A., Laoye O.J., and Aderounmu A.F. Combination of quinine, quinidine and cinchonine for the treatment of acute falciparum malaria: correlation with the susceptibility of Plasmodium falciparum to the cinchona alkaloids in vitro. Trans. R. Soc. Trop. Med. Hyg. 84 (1990) 626-629
24. Tan H.W., and Ch'ng S.L. Drug interaction between cyclosporine A and quinine in a renal transplant patient with malaria. Singapore Med. J. 32 (1991) 189-190
25. Touze J.E., Heno P., Fourcade L., Deharo J.C., Thomas G., Bohan S., Paule P., Riviere P., Kouassi E., and Buguet A. The effects of antimalarial drugs on ventricular repolarization. Am. J. Trop. Med. Hyg. 67 (2002) 54-60
26. Zhao X.J., and Ishizaki T. The in vitro hepatic metabolism of quinine in mice, rats and dogs: comparison with human liver microsomes. J. Pharmacol. Exp. Ther. 283 (1997) 1168-1176
27. Zhao X.J., and Ishizaki T. A further interaction study of quinine with clinically important drugs by human liver microsomes: determinations of inhibition constant (Ki) and type of inhibition. Eur. J. Drug Metab. Pharmacokinet. 24 (1999) 272-278